
Herewith we offer to you various documents for download purposes, published in or related to year 2004.
To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.
Corporate Governance | |
|---|---|
Declaration of Conformity 2004 |
|
Investor Handouts | |
|---|---|
Full Year 2004 |
|
Q4 2004 Analyst and Investor Briefing |
|
Q3 2004 |
|
Q3 2004 Analyst and Investor Briefing |
|
Q2 2004 |
|
Q2 2004 Analyst and Investor Briefing |
|
Q1 2004 |
|
Q1 2004 Analyst and Investor Briefing |
|
Presentations | ||
|---|---|---|
September 28, 2004 | Presentation by Dr. Wolfgang Plischke, Member of the Bayer HealthCare Executive Committee and President of the Pharmaceuticals Division |
|
June 09, 2004 | Presentation by Dr. Wolfgang Plischke, Member of the Bayer HealthCare Executive Committee and President of the Pharmaceuticals Division |
|
May 18, 2004 | Presentation by Dr. Hagen Noerenberg, CEO of Bayer MaterialsScience AG |
|
May 11, 2004 | Presentation by Dr. Wolfgang Plischke, Member of the Bayer HealthCare Executive Committee and President of the Pharmaceuticals Division |
|
April 01, 2004 | Presentation by Dr. Esmail Zirakparvar, Member of the Board of Management of Bayer CropScience AG |
|
March 30, 2004 | Presentation by Werner Wenning, CEO of Bayer AG |
|
February 24, 2004 | Presentation by Dr. Bernward Garthoff, Member of the Board of Management of Bayer CropScience AG |
|
January 19, 2004 | Presentation by Klaus Kühn, CFO of Bayer AG |
|
Group Key Figures | |
|---|---|
2004 / 2003 |
|
Stock Information | |
|---|---|
Stock Key Figures 2004 / 2003 |
|
Share Price Performance 2004 |
|
Daily Share Prices 2004 |
|
Stock Listings and Trading Volumes 2004 |
|
News and Ad-hoc Messages | |
|---|---|
News Overview 2004 |
|
Ad-hoc Message | Bayer enters strategic pharmaceuticals alliance with Schering-Plough |
| |
Ad-hoc Message | Q1 04 underlying EBIT expected to be about 25-30% above analysts’ expectations |
| |